Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by numerous analysts, with many highlighting its robust growth potential, especially in the Asian market and wealth management. The company has successfully increased its dividend yield, currently sitting at approximately 4-5%, while its price-to-earnings (PE) ratio remains attractive compared to peers in the banking sector. Analysts have noted concerns over potential earnings drops but maintain a long-term positive outlook, suggesting that MFC is suitable for income-focused investors. While many emphasize the reliability of MFC's dividend and its strong position in life insurance, there are mixed feelings regarding its growth prospects compared to other financial institutions. Overall, the sentiment leans towards MFC being a solid choice for those seeking steady income and moderate growth, but some experts advise caution regarding market volatility.

Consensus

Positive

Valuation

Fair Value

Similar

GWO

DON'T BUY

Financial seasonality runs from mid-January until April 14. Not a big fan of this company. Still linked to the market and will probably do well when the market does well. Chart shows a bearish pattern with lower highs.

HOLD

Results have been disappointing over the last few quarters. Will be coming out with new results this week. In the doghouse at the moment. Earnings are hard to project.

HOLD

Doesn’t like it. He is an earnings guy. You want to see an increase in earnings. It’s a value investment. Right now they just don’t have the earnings but if you hold it long enough it will go up.

COMMENT

This one and Sun Life (SLF-T) have almost identical seasonality. Usually they reach a very important low right around the end of February and then take a very good move right through until the end of May. They then go flat for a time. Reporting earnings next week, which should be very good. Technically it has a base and is not moving much.

DON'T BUY

Expects a lot of visibility on their earnings coming up very shortly. Will probably take 2 or 3 quarters to get the confidence back. Avoiding this sector altogether at the moment.

TOP PICK

Insurance industry used to trade at a premium to the banking industry but is now at a discount. Has very strong franchise in Canada, US and internationally. Having capital is not a problem for them anymore.

BUY

CEO doing a reasonably good job. It was the previous CEO that was a problem. Core business is doing very well. If we see rising interest rates and a rising stock market, they will do reasonable well.

TOP PICK

Banks have had a run-up but lifecos have lagged this recent move. He expects the markets are going to recover.

COMMENT

Pretty fairly valued. Believes the market is going to be much better over the next several years. They should be a beneficiary. Likes the diversification, especially in the Asian market.

STRONG BUY

Growing aggressively in emerging markets. Very cheap. Has chronically under performed and trading at its lowest valuations. Will benefit if interest rates rise, as he expects them to. Will be a very stable, low growth company.

DON'T BUY

Likelihood of increasing dividends in the next year would be a surprise to him. Still not sure how regulators are going to deal with Life Insurance companies capital. His calculations show that this one has the highest upside potential in the financials but doesn't know how long it will take to get there.

DON'T BUY

His least favourite in the lifecos. Operationally has been the best in North America with great growth potential in the far east. Got hung up with segregated funds in Canada and variable annuities in the US. Doesn't think they are even at half yet of hedging their portfolio. Will take a long time for investor confidence to come back.

TOP PICK

Did their last security issue to build a better financial picture for themselves. Doesn't think it's going up over the next 6 months but likes it for the long term. Price to Book is only about 1.3 times. Have growth in the US through John Hancock and in Asia.

DON'T BUY

Has Asian exposure, which he loves. However still in the penalty box for cutting dividends. Until they get out of this, there is no real rush to get into it.

DON'T BUY

Spent the last year trying to put its capital base back in “fortress” category. A couple of things are holding the company back. 1) It is most exposed of all the insurance companies to equity markets. 2) Pending changes to some of the capital requirements could put a crimp in the seg fund business.

Showing 1,486 to 1,500 of 2,279 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)